131 related articles for article (PubMed ID: 38176644)
1. GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway.
Jurado-Aguilar J; Barroso E; Bernard M; Zhang M; Peyman M; Rada P; Valverde ÁM; Wahli W; Palomer X; Vázquez-Carrera M
Metabolism; 2024 Mar; 152():155772. PubMed ID: 38176644
[TBL] [Abstract][Full Text] [Related]
2. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of metformin on pulmonary fibrosis caused by paraquat through activating AMP-activated protein kinase pathway].
Liu T; Gao L; Wang J; Wu L; Zhou M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Dec; 35(12):1309-1315. PubMed ID: 38149395
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
Yadav H; Devalaraja S; Chung ST; Rane SG
J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
[TBL] [Abstract][Full Text] [Related]
5. (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway.
Hsieh YC; Lee KC; Lei HJ; Lan KH; Huo TI; Lin YT; Chan CC; Schnabl B; Huang YH; Hou MC; Lin HC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):813-838. PubMed ID: 34087453
[TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
Aguilar-Recarte D; Barroso E; Zhang M; Rada P; Pizarro-Delgado J; Peña L; Palomer X; Valverde ÁM; Wahli W; Vázquez-Carrera M
Pharmacol Res; 2023 Jan; 187():106578. PubMed ID: 36435271
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.
Lu J; Shi J; Li M; Gui B; Fu R; Yao G; Duan Z; Lv Z; Yang Y; Chen Z; Jia L; Tian L
Life Sci; 2015 Apr; 127():59-65. PubMed ID: 25744403
[TBL] [Abstract][Full Text] [Related]
8. GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK.
Aguilar-Recarte D; Barroso E; Gumà A; Pizarro-Delgado J; Peña L; Ruart M; Palomer X; Wahli W; Vázquez-Carrera M
Cell Rep; 2021 Aug; 36(6):109501. PubMed ID: 34380027
[TBL] [Abstract][Full Text] [Related]
9. [Research of miR-29a on TGF-β1/Smad3 pathway in pulmonary fibrosis induced by neodymium oxide].
Yun YD; Wang SH
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Jan; 42(1):10-15. PubMed ID: 38311943
[No Abstract] [Full Text] [Related]
10. AMPK mediates energetic stress-induced liver GDF15.
Townsend LK; Weber AJ; Day EA; Shamshoum H; Shaw SJ; Perry CGR; Kemp BE; Steinberg GR; Wright DC
FASEB J; 2021 Jan; 35(1):e21218. PubMed ID: 33337559
[TBL] [Abstract][Full Text] [Related]
11. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
12. A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway.
Meng X; Kuang H; Wang Q; Zhang H; Wang D; Kang T
Int Immunopharmacol; 2023 Jun; 119():110180. PubMed ID: 37068337
[TBL] [Abstract][Full Text] [Related]
13. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
14. AMPK inhibits Smad3-mediated autoinduction of TGF-β1 in gastric cancer cells.
Zou J; Li C; Jiang S; Luo L; Yan X; Huang D; Luo Z
J Cell Mol Med; 2021 Mar; 25(6):2806-2815. PubMed ID: 33538080
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
16. Identification of growth differentiation factor 15 as a pro-fibrotic factor in mouse liver fibrosis progression.
Qi P; Ma MZ; Kuai JH
Int J Exp Pathol; 2021 Jun; 102(3):148-156. PubMed ID: 33983642
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism.
Stone JD; Holt AW; Vuncannon JR; Brault JJ; Tulis DA
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1251-9. PubMed ID: 26276823
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis.
Liu D; Wang K; Li K; Xu R; Chang X; Zhu Y; Sun P; Han X
Cell Death Dis; 2019 Jun; 10(6):458. PubMed ID: 31189885
[TBL] [Abstract][Full Text] [Related]
20. Targeting myosin 1c inhibits murine hepatic fibrogenesis.
Arif E; Wang C; Swiderska-Syn MK; Solanki AK; Rahman B; Manka PP; Coombes JD; Canbay A; Papa S; Nihalani D; Aspichueta P; Lipschutz JH; Syn WK
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1044-G1053. PubMed ID: 33908271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
